Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Belarusian President…
Stay informed with free updatesSimply sign up to the Oil & Gas industry myFT Digest -- delivered directly to your…
I recently profiled JPMorgan Chase & Co.'s (JPM) dividend increase and the underlying strength of…
Receive free Markets updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
With the S&P 500 hovering around 12-month highs despite macro jitters, a common question investors…
Receive free Deutsche Bank AG updatesWe’ll send you a myFT Daily Digest email rounding up…
Amid stiff competition in a generally saturated market, American oral care giant Colgate-Palmolive (NYSE:CL) has…
Receive free Chinese economy updatesWe’ll send you a myFT Daily Digest email rounding up the…
These 3 are smaller than the competition, make no mistake they bring a lot to…
Insufficient access to renewable energy in their home markets has left Asia’s biggest chipmakers lagging…
Introduction Aldeyra Therapeutics (NASDAQ:ALDX) is a biotech firm focused on creating therapies for immune-mediated diseases.…
You can enable subtitles (captions) in the video player The story of Adani is the…
On July 6, 2023, the Food and Drug Administration granted full approval to Biogen (NASDAQ:BIIB)…
Receive free SVB Financial Group updatesWe’ll send you a myFT Daily Digest email rounding up…
Investors in Eli Lilly and Company (NYSE:LLY) have benefited from its solid execution in its…
© AP The US and Germany are under intense pressure from other allies to show…
Luxury fashion house Burberry (OTCPK:BURBY) (OTCPK:BBRYF) was facing some headwinds when I last covered it…
Sign in to your account